Presentation is loading. Please wait.

Presentation is loading. Please wait.

Erythrodermic psoriasis after discontinuation of ixekizumab

Similar presentations


Presentation on theme: "Erythrodermic psoriasis after discontinuation of ixekizumab"— Presentation transcript:

1 Erythrodermic psoriasis after discontinuation of ixekizumab
Kathryn Anne Potter, MD, Kiran Motaparthi, MD, Jennifer J. Schoch, MD  JAAD Case Reports  Volume 4, Issue 1, Pages (January 2018) DOI: /j.jdcr Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions

2 Fig 1 Exfoliative erythroderma on bilateral lower extremities.
JAAD Case Reports 2018 4, 22-23DOI: ( /j.jdcr ) Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions

3 Fig 2 Exfoliative erythroderma of face.
JAAD Case Reports 2018 4, 22-23DOI: ( /j.jdcr ) Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions

4 Fig 3 Classic features of psoriasis are seen, including regular epidermal hyperplasia, hypogranulosis, dilated vessels within the dermal papillae, and numerous neutrophils in the stratum corneum and epidermis. (A and B, Hematoxylin-eosin stain; original magnifications: A, ×100; B, ×200.) JAAD Case Reports 2018 4, 22-23DOI: ( /j.jdcr ) Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions


Download ppt "Erythrodermic psoriasis after discontinuation of ixekizumab"

Similar presentations


Ads by Google